Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney
- PMID: 3123798
Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney
Abstract
Platelet-activating factor (PAF) is a lipid mediator of inflammation believed to play a role in glomerulonephritis by favoring immune complex formation and modulating the subsequent inflammatory reaction. Some evidence indicates that PAF may also be one of the mediators of proteinuria. Previous work suggested that PAF can increase glomerular permeability to proteins, activating platelets and inflammatory cells to release cationic proteins. In the present study, we addressed the possibility that PAF might directly increase glomerular permeability to proteins independently of platelets and inflammatory cells. We used a preparation of isolated rat kidney perfused with an artificial cell-free medium. After stabilization and two 10-minute control clearance periods, kidneys perfused in a closed circuit were exposed to PAF (2 nM or 10 nM final concentration) or 2-lyso-PAF (10 nM final concentration) or vehicle for 40 minutes. Glomerular filtration rate, measured as creatinine clearance, and renal vascular resistance did not significantly change when either PAF (2 nM or 10 nM) or 2-lyso-PAF, or vehicle were added to the perfusion fluid. Unlike vehicle or 2-lyso-PAF, addition of PAF at the final concentration of 2 and 10 nM to the perfusate produced a dose-dependent progressive increase in urinary protein excretion. PAF-induced proteinuria was prevented by L-652,731, a specific PAF receptor antagonist, suggesting that PAF's effect on glomerular permeability to proteins is likely to be related to its biologic activity. Several pharmacologic manipulations addressed to the potential mediators of PAF effect on glomerular permeability to proteins would exclude that the effect of PAF on isolated perfused kidney is mediated by cyclooxygenase or lipoxygenase products, or is the result of oxygen-free radical generation. The possibility that PAF enhances glomerular permeability to proteins by changing the glomerular barrier electrostatic properties was explored using polyethylene-imine. Electron microscopy examination revealed no difference in the distribution of electron-dense deposits along the glomerular basement membrane in kidneys exposed to 10 nM PAF or vehicle.
Similar articles
-
Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.J Lab Clin Med. 1987 Aug;110(2):196-206. J Lab Clin Med. 1987. PMID: 2955066
-
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.Lab Invest. 1985 Jun;52(6):617-30. Lab Invest. 1985. PMID: 3925239
-
Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats.Am J Physiol. 1991 Jul;261(1 Pt 2):F85-90. doi: 10.1152/ajprenal.1991.261.1.F85. Am J Physiol. 1991. PMID: 1713421
-
Role of platelet-activating factor in renal immune injury and proteinuria.Am J Nephrol. 1990;10 Suppl 1:98-104. doi: 10.1159/000168202. Am J Nephrol. 1990. PMID: 2256482 Review.
-
Platelet-activating factor and the kidney.Am J Physiol. 1986 Jul;251(1 Pt 2):F1-11. doi: 10.1152/ajprenal.1986.251.1.F1. Am J Physiol. 1986. PMID: 3089026 Review.
Cited by
-
Rapid resolution liquid chromatography coupled with quadrupole time-of-flight mass spectrometry-based metabolomics approach to study the effects of jieduquyuziyin prescription on systemic lupus erythematosus.PLoS One. 2014 Feb 5;9(2):e88223. doi: 10.1371/journal.pone.0088223. eCollection 2014. PLoS One. 2014. PMID: 24505438 Free PMC article.
-
The role of platelet-activating factor (PAF) in experimental glomerular injury.Lipids. 1991 Dec;26(12):1310-5. doi: 10.1007/BF02536555. Lipids. 1991. PMID: 1819722 Review.
-
Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis.Clin Exp Immunol. 1995 Aug;101(2):334-40. doi: 10.1111/j.1365-2249.1995.tb08360.x. Clin Exp Immunol. 1995. PMID: 7648718 Free PMC article.
-
Role of platelets in progressive glomerular diseases.Pediatr Nephrol. 1995 Aug;9(4):495-502. doi: 10.1007/BF00866739. Pediatr Nephrol. 1995. PMID: 7577419 Review.
-
The effects of R-75,317 on antiglomerular basement membrane glomerulonephritis in rats.Lipids. 1991 Dec;26(12):1316-9. doi: 10.1007/BF02536556. Lipids. 1991. PMID: 1819723